Woodline Partners LP Amneal Pharmaceuticals, Inc. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 567,060 shares of AMRX stock, worth $5.09 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
567,060
Previous 1,604,531
64.66%
Holding current value
$5.09 Million
Previous $13.3 Million
66.36%
% of portfolio
0.03%
Previous 0.12%
Shares
4 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
124MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$133 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$111 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$101 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$96.2 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$80.6 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.36B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...